Pharmacokinetic Studies on ditazole (cas 18471-20-0), a Novel Inhibitor of Platelet Aggregation

Add time:09/04/2019    Source:sciencedirect.com

The distribution of ditazole in blood and tissues of rats was determined by a simple GLC technique. Ditazole, after intravenous injection in rats (20 mg/kg), entered preferentially into the brain, the liver, and the heart in decreasing order. In the epididymal adipose tissue, the drug was present only in small amounts. Ditazole disappeared from the rat organs 4 hr after the treatment. The apparent ditazole half-life in rat blood was 41 min, the volume of distribution was 2.068 liters/kg, and the body clearance was 0.0345 liter/kg/min.

We also recommend Trading Suppliers and Manufacturers of ditazole (cas 18471-20-0). Pls Click Website Link as below: cas 18471-20-0 suppliers

Prev:PaperThe vascular protection of ditazole (cas 18471-20-0) and its effect on arachidonic acid metabolism
Next:[3-[4-(4,5-diphenyl-2-oxazolyl)-5-oxazolyl]phenoxy]acetic acid (BMY 45778) is a potent non-prostanoid prostacyclin partial agonist: Effects on platelet aggregation, adenylyl cyclase, cAMP levels, protein kinase, and iloprost binding)